HLA-C and neoplasm: TCR-transduced NK cells retain their natural cytotoxicity in addition to the newly-acquired MHC-restricted capabilities, and are therefore resistant to HLA-loss, which is a main mechanism of tumor evasion under TCR therapy [96,97,98].